Please use this identifier to cite or link to this item:
Title: A comparison of characteristics and outcomes of patients admitted to the ICU with asthma in Australia and New Zealand and United states.
Austin Authors: Abdelkarim, Hussam;Durie, Matthew;Bellomo, Rinaldo ;Bergmeir, Christoph;Badawi, Omar;El-Khawas, Khaled;Pilcher, David
Affiliation: Department of eICU Research and Development, Philips Healthcare, Baltimore, Maryland, USA
Faculty of Information Technology, Monash University, Clayton, VIC, Australia
Intensive Care Unit, Melbourne Health, Parkville, VIC, Australia
School of Medicine, University of Melbourne, Parkville, Melbourne, Australia
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
Centre for Outcome and Resource Evaluation, Australian and New Zealand Intensive Care Society, Melbourne, Australia
Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Department of Intensive Care, Alfred Hospital, Melbourne, VIC, Australia
Department of Intensive Care, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 31-Jan-2019 2019-01-31
Publication information: The Journal of asthma : official journal of the Association for the Care of Asthma 2019; online first: 31 January
Abstract: To compare the characteristics, use of invasive ventilation and outcomes of patients admitted with critical asthma syndrome (CAS) to ICUs in Australia and New Zealand (ANZ), and a large cohort of ICUs in the United States (US). We examined two large databases of ICU for patients admitted with CAS in 2014 and 2015. We obtained, analyzed, and compared information on demographic and physiological characteristics, use of invasive mechanical ventilation, and clinical outcome and derived predictive models. Overall, 2202 and 762 patients were admitted with a primary diagnosis of CAS in the ANZ and US databases respectively (0.73% vs. 0.46% of all ICU admissions, P < 0.001). A similar percentage of patients received invasive mechanical ventilation in the first 24 h (24.7% vs. 24.4%, P = 0.87) but ANZ patients had lower respiratory rates and higher PaCO2 levels. Overall mortality was low (1.23 for ANZ and 1.71 for USA; P = 0.36) and even among invasively ventilated patients (2.4% for ANZ vs. 1.1% for USA; P = 0.38). However, ANZ patients also had longer length of stay in ICU (43 vs. 37 h, P = 0.001) and hospital (105 vs. 78 h, P = 0.003). Patients admitted to ANZ and USA ICU with CAS are broadly similar and have a low and similar rate of invasive ventilation and mortality. However, ANZ patients made up a greater proportion of ICU patients and had longer ICU and hospital stays. These findings provide a modern invasive ventilation and mortality rates benchmark for future studies of CAS.
DOI: 10.1080/02770903.2019.1571082
ORCID: 0000-0002-4473-9005
PubMed URL: 30701997
Type: Journal Article
Subjects: Critical care
Intensive Care Units
Appears in Collections:Journal articles

Show full item record

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.